Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-level characteristics recognition of cancer core therapeutic targets and drug screening for a broader patient population. | Front Pharmacol | 2023 | 38074121 | PubTator, text mining | PubMed |
| RAAS-deficient organoids indicate delayed angiogenesis as a possible cause for autosomal recessive renal tubular dysgenesis. | Nat Commun | 2023 | 38071212 | PubTator, text mining | PubMed |
| Antidiabetic Activity, Molecular Docking, and ADMET Properties of Compounds Isolated from Bioactive Ethyl Acetate Fraction of Ficus lutea Leaf Extract. | Molecules | 2023 | 38067448 | PubTator, text mining | PubMed |
| Stereoselectivity in Cell Uptake by SLC22 Organic Cation Transporters 1, 2, and 3. | J Med Chem | 2023 | 38052451 | PubTator, text mining | PubMed |
| Predictors of gastrointestinal complaints in patients on metformin therapy. | Open Med (Wars) | 2023 | 38045859 | PubTator, text mining | PubMed |
| Selective activation of intracellular β1AR using a spatially restricted antagonist. | bioRxiv | 2023 | 38045405 | PubTator, text mining | PubMed |
| Integrated investigation and discovery of therapeutic targets for 3-hydroxybakuchiol against diabetes based on molecular docking studies and cell experiments. | BMC Complement Med Ther | 2023 | 38031191 | PubTator, text mining | PubMed |
| Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations. | Diabetes Metab Syndr Obes | 2023 | 38028995 | PubTator, text mining | PubMed |
| Precision, integrative medicine for pain management in sickle cell disease. | Front Pain Res (Lausanne) | 2023 | 38028431 | PubTator, text mining | PubMed |
| SLC22A3 that encodes organic cation transporter-3 is associated with prognosis and immunogenicity of human lung squamous cell carcinoma. | Transl Lung Cancer Res | 2023 | 38025816 | PubTator, text mining | PubMed |
| Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel. | J Pharm Anal | 2023 | 38024860 | PubTator, text mining | PubMed |
| Choline metabolism and its implications in cancer. | Front Oncol | 2023 | 38023163 | PubTator, text mining | PubMed |
| Real-Life Experience With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Turkey. | Cureus | 2023 | 38022124 | PubTator, text mining | PubMed |
| Study Models of Drug-Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels. | Molecules | 2023 | 38005253 | PubTator, text mining | PubMed |
| A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy. | Pharmaceutics | 2023 | 38004602 | PubTator, text mining | PubMed |
| Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia. | Pharmaceutics | 2023 | 38004514 | PubTator, text mining | PubMed |
| Insight into Risk Factors, Pharmacogenetics/Genomics, and Management of Adverse Drug Reactions in Elderly: A Narrative Review. | Pharmaceuticals (Basel) | 2023 | 38004408 | PubTator, text mining | PubMed |
| Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride. | J Pers Med | 2023 | 38003881 | PubTator, text mining | PubMed |
| Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions. | Int J Mol Sci | 2023 | 38003734 | PubTator, text mining | PubMed |
| Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms. | Genes (Basel) | 2023 | 38002991 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=8